141 related articles for article (PubMed ID: 35753955)
61. Treatment of carcinoma of the anal canal at Groote Schuur Hospital.
Robertson B; Shepherd L; Abratt RP; Hunter A; Goldberg P
S Afr Med J; 2012 May; 102(6):559-61. PubMed ID: 22668963
[TBL] [Abstract][Full Text] [Related]
62. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
[TBL] [Abstract][Full Text] [Related]
63. Variation in the Use of Chemoradiotherapy for Stage II and III Anal Cancer: Analysis of the National Cancer Data Base.
Geltzeiler CB; Tsikitis VL; Kim JS; Thomas CR; Herzig DO; Lu KC
Ann Surg Oncol; 2016 Nov; 23(12):3934-3940. PubMed ID: 27444107
[TBL] [Abstract][Full Text] [Related]
64. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
65. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
66. Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.
Hagemans JAW; Blinde SE; Nuyttens JJ; Morshuis WG; Mureau MAM; Rothbarth J; Verhoef C; Burger JWA
Ann Surg Oncol; 2018 Jul; 25(7):1970-1979. PubMed ID: 29691737
[TBL] [Abstract][Full Text] [Related]
67. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C
BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909
[TBL] [Abstract][Full Text] [Related]
68. Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma.
Thind G; Johal B; Follwell M; Kennecke HF
Radiat Oncol; 2014 May; 9():124. PubMed ID: 24885554
[TBL] [Abstract][Full Text] [Related]
69. Surveillance of Anal Canal Cancers.
Adams R
Surg Oncol Clin N Am; 2017 Jan; 26(1):127-132. PubMed ID: 27889031
[TBL] [Abstract][Full Text] [Related]
70. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Gunderson LL; Winter KA; Ajani JA; Pedersen JE; Moughan J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett CG
J Clin Oncol; 2012 Dec; 30(35):4344-51. PubMed ID: 23150707
[TBL] [Abstract][Full Text] [Related]
71. DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma.
Kim S; Jary M; Mansi L; Benzidane B; Cazorla A; Demarchi M; Nguyen T; Kaliski A; Delabrousse E; Bonnetain F; Letondal P; Bosset JF; Valmary-Degano S; Borg C
Ann Oncol; 2013 Dec; 24(12):3045-50. PubMed ID: 24114858
[TBL] [Abstract][Full Text] [Related]
72. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
[TBL] [Abstract][Full Text] [Related]
73. [A Case of Squamous Cell Cancer of the Anus Treated with Chemoradiotherapy].
Takeuchi T; Inoue A; Nishizawa Y; Kagawa Y; Aomatsu M; Tsuji Y; Hirano M; Komatsu H; Tomokuni A; Miyazaki Y; Motoori M; Fushimi H; Iwase K; Gotoh M; Fujitani K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2133-2135. PubMed ID: 35045516
[TBL] [Abstract][Full Text] [Related]
74. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
75. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal.
Eng C; Jácome AA; Das P; Chang GJ; Rodriguez-Bigas M; Skibber JM; Wolff RA; Qiao W; Xing Y; Sethi S; Ohinata A; Crane CH
Clin Colorectal Cancer; 2019 Dec; 18(4):301-306. PubMed ID: 31350201
[TBL] [Abstract][Full Text] [Related]
76. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.
Kachnic LA; Winter K; Myerson RJ; Goodyear MD; Willins J; Esthappan J; Haddock MG; Rotman M; Parikh PJ; Safran H; Willett CG
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):27-33. PubMed ID: 23154075
[TBL] [Abstract][Full Text] [Related]
77. Chemoradiation in rectal squamous cell carcinoma: Bi-institutional case series.
Loganadane G; Servagi-Vernat S; Schernberg A; Schlienger M; Touboul E; Bosset JF; Huguet F
Eur J Cancer; 2016 May; 58():83-9. PubMed ID: 26974707
[TBL] [Abstract][Full Text] [Related]
78. The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study.
Yoder AK; Lakomy DS; Dong Y; Raychaudhury S; Royse K; Hartman C; Richardson P; White DL; Kramer JR; Lin LL; Chiao E
BMC Cancer; 2021 Jul; 21(1):776. PubMed ID: 34225709
[TBL] [Abstract][Full Text] [Related]
79. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort.
Bacci M; Quero L; Barbier E; Parrot L; Juguet F; Pommier P; Bazire L; Etienney I; Baba-Hamed N; Spindler L; François E; Ronchin P; Campo ERD; Lemanski C; Lièvre A; Siproudhis L; Abramowitz L; Lepage C; Vendrely V
Dig Liver Dis; 2021 Jun; 53(6):776-784. PubMed ID: 33867291
[TBL] [Abstract][Full Text] [Related]
80. Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.
Kim KH; Chang JS; Keum KC; Ahn JB; Lee CG; Koom WS
Radiat Oncol J; 2013 Mar; 31(1):25-33. PubMed ID: 23620866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
